002675SZSE

Announcement of Resolutions from the 2025 Annual Shareholders' Meeting

Yantai Dongcheng Pharmaceutical Group Co.,Ltd.·April 15, 2026

✨ AI Summary

The announcement details the resolutions passed during the 2025 Annual Shareholders' Meeting of Yantai Dongcheng Pharmaceutical Group Co., Ltd. Key decisions included the approval of the 2025 Board Work Report, Financial Settlement Report, and Profit Distribution Plan. All proposals received overwhelming support, with no rejections noted. The meeting confirmed compliance with legal and regulatory requirements, ensuring the validity of the proceedings.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

Stock Code: 002675

Stock Abbreviation: Dongcheng Pharmaceutical

Announcement Number: 2026-027

Yantai Dongcheng Pharmaceutical Group Co., Ltd. Announcement of Resolutions from the 2025 Annual Shareholders' Meeting

Special Reminder:

No proposals were rejected during this shareholders' meeting.
This meeting did not involve changes to previous resolutions.

I. Meeting Details

Meeting Time:
- On-site meeting: April 15, 2026, at 14:50
- Online voting: April 15, 2026, from 9:15 to 9:25, 9:30 to 11:30, and 13:00 to 15:00; voting via the Shenzhen Stock Exchange Internet voting system was available from 9:15 to 15:00 on April 15, 2026.
Meeting Location: Company conference room, No. 7 Changbai Mountain Road, Yantai Economic and Technological Development Zone.
Voting Methods: On-site voting and online voting.
Meeting Convenor: The company's Board of Directors.
Meeting Chair: Mr. Youyi Zhou, Chairman.
The convening and conducting of this shareholders' meeting complied with the Company Law, the Rules for Shareholders' Meetings of Listed Companies, and other legal and regulatory documents, as well as the Company’s Articles of Association.

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.